Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 43, 2021 - Issue 3
244
Views
1
CrossRef citations to date
0
Altmetric
Original Research Paper

Prolonged distal latency of the median motor nerve is associated with poor prognosis in amyotrophic lateral sclerosis

ORCID Icon, , , &
Pages 191-198 | Received 04 Jun 2020, Accepted 04 Oct 2020, Published online: 15 Oct 2020

References

  • Brown RH, Al-Chalabi A, Longo DL. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162–172.
  • Chio A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotrophic lateral sclerosis. 2009;10(5–6):310–323.
  • Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (Phase III). J Neurol Sci. 1999;169(1–2):13–21.
  • Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2006;77(3):390–392.
  • Silva CS, Rodrigues FB, Duarte GS, et al. Prognostic value of phrenic nerve conduction study in amyotrophic lateral sclerosis: systematic review and meta-analysis. Clin Neurophysiol. 2020;131(1):106–113.
  • Evangelista T, Carvalho M, Conceicao I, et al. Motor neuropathies mimicking amyotrophic lateral sclerosis/motor neuron disease. J Neurol Sci. 1996;139(Suppl):95–98.
  • Cornblath DR, Kuncl RW, Mellits ED, et al. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve. 1992;15(10):1111–1115.
  • Morris J. Amyotrophic Lateral Sclerosis (ALS) and related motor neuron diseases: an overview. Neurodiagn J. 2015;55(3):180–194.
  • Mills KR, Nithi KA. Peripheral and central motor conduction in amyotrophic lateral sclerosis. J Neurol Sci. 1998;159(1):82–87.
  • Kothari MJ, Rutkove SB, Logigian EL, et al. Coexistent entrapment neuropathies in patients with amyotrophic lateral sclerosis. Arch Phys Med Rehabil. 1996;77(11):1186–1188.
  • Mohammadi B, Krampfl K, Kollewe K, et al. Correlation between distal motor latency and compound muscle action potential in amyotrophic lateral sclerosis. Neurol Res. 2007;29(5):425–428.
  • Noto Y, Kanai K, Misawa S, et al. Distal motor axonal dysfunction in amyotrophic lateral sclerosis. J Neurol Sci. 2011;302(1–2):58–62.
  • Mori A, Nodera H, Takamatsu N, et al. Focal nerve enlargement is not the cause for increased distal motor latency in ALS: sonographic evaluation. Clin Neurophysiol. 2015;126(8):1632–1637.
  • Andrews JA, Shefner JM. Clinical neurophysiology of anterior horn cell disorders. Handb Clin Neurol. 2019;161:317–326.
  • Suzuki K, Katsuno M, Banno H, et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain. 2008;131(Pt 1):229–239.
  • Emeryk-Szajewska B, Kopéc J, Karwanska A. The reorganization of motor units in motor neuron disease. Muscle Nerve. 1997;20(3):306–315.
  • Dadon-Nachum M, Melamed E, Offen D. The “dying-back” phenomenon of motor neurons in ALS. J Mol Neurosci. 2011;43(3):470–477.
  • Fischer LR, Culver DG, Tennant P, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185(2):232–240.
  • Brooks BR, Miller RG, Swash M. et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1(5):293–299.
  • Kimura F, Fujimura C, Ishida S, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66(2):265–267.
  • Kasius KM, Claes F, Verhagen WIM, et al. Motor nerve conduction tests in carpal tunnel syndrome. Front Neurol. 2019;10:149.
  • Nishi R, Koike H, Ohyama K, et al. Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA. Neurology. 2020;94(16):e1726–e1737.
  • Aminoff MJ, Daroff RB, et al. Encyclopedia of the neurological sciences. 2nd ed. 2014.
  • Barboi AC, Barkhaus PE. Electrodiagnostic testing in neuromuscular disorders. Neurol Clin. 2004;22(3):619–641.
  • Imai E, Nakamura T, Atsuta N, et al. A nerve conduction study predicts the prognosis of sporadic amyotrophic lateral sclerosis. J Neurol. 2020;267(9):2524–2532.
  • Wirguin I, Brenner T, Argov Z, et al. Multifocal motor nerve conduction abnormalities in amyotrophic lateral sclerosis. J Neurol Sci. 1992;112(1–2):199–203.
  • Argyriou AA, Polychronopoulos P, Talelli P, et al. F wave study in amyotrophic lateral sclerosis: assessment of balance between upper and lower motor neuron involvement. Clin Neurophysiol. 2006;117(6):1260–1265.
  • Park D, Park JS. Terminal latency abnormality in amyotrophic lateral sclerosis without split hand syndrome. Neurol Sci. 2017;38(5):775–781.
  • Schulte-Mattler WJ, Jakob M, Zierz S. Focal sensory nerve abnormalities in patients with amyotrophic lateral sclerosis. J Neurol Sci. 1999;162(2):189–193.
  • Atroshi I, Gummesson C, Johnsson R, et al. Prevalence of carpal tunnel syndrome in a general population. Jama. 1999;282(2):153–158.
  • Silverstein BA, Fan ZJ, Bonauto DK, et al. The natural course of carpal tunnel syndrome in a working population. Scand J Work Environ Health. 2010;36(5):384–393.
  • Kollewe K, Koerner S, Ilsemann J, et al. Nerve compression syndromes in ALS: a retrospective analysis in 554 patients. Amyotrophic Lateral Sclerosis 2011;12(5):349–351.
  • Bae JS, Sawai S, Misawa S, et al. Differences in excitability properties of FDI and ADM motor axons. Muscle Nerve. 2009;39(3):350–354.
  • Shibuya K, Misawa S, Nasu S, et al. Split hand syndrome in amyotrophic lateral sclerosis: different excitability changes in the thenar and hypothenar motor axons. J Neurol Neurosurg Psychiatry. 2013;84(9):969–972.
  • de Carvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve. 2000;23(3):344–352.
  • Kelly JJ Jr., Thibodeau L, Andres PL, et al. Use of electrophysiologic tests to measure disease progression in ALS therapeutic trials. Muscle Nerve. 1990;13(6):471–479.
  • Louwerse ES, Posthumus Meyjes FE, Sillevis Smitt JH, et al. Prognostic values of electroneurographic and electromyographic features in amyotrophic lateral sclerosis. J Neurol Sci. 1995;129(Suppl):29.
  • Vucic S, Kiernan MC. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol. 2006;117(7):1458–1466.
  • Nakata M, Kuwabara S, Kanai K, et al. Distal excitability changes in motor axons in amyotrophic lateral sclerosis. Clin Neurophysiol. 2006;117(7):1444–1448.
  • Shibuya K, Misawa S, Kimura H, et al. Increased motor axonal persistent sodium currents predict rapid functional declines in amyotrophic lateral sclerosis. Neurol Clin Neurosci. 2016;4(3):108–111.
  • Kanai K, Shibuya K, Sato Y, et al. Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2012;83(7):734–738.
  • Kovalchuk MO, Heuberger J, Sleutjes B. et al. Acute effects of riluzole and retigabine on axonal excitability in patients with amyotrophic lateral sclerosis: a randomized, double‐blind, placebo‐controlled, crossover trialClin pharmacol Ther. 2018;104(6):1136–1145.
  • Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6(11):994–1003.
  • Nidos A, Kasselimis DS, Simos PG, et al. Frontotemporal dysfunction in amyotrophic lateral sclerosis: a discriminant function analysis. Neurodegener Dis. 2016;16(3–4):140–146.
  • Ahn SW, Kim SH, Kim JE. et al. Frontal assessment battery to evaluate frontal lobe dysfunction in ALS patients, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2011;38(2):242–246.
  • Terada T, Miyata J, Obi T, et al. Frontal assessment battery and frontal atrophy in amyotrophic lateral sclerosis. Brain Behav. 2017;7(6):e00707.
  • Lomen-Hoerth C, Murphy J, Langmore S, et al. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60(7):1094–1097.
  • Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76(14):1263–1269.
  • Mitsuyama Y, Inoue T. Clinical entity of frontotemporal dementia with motor neuron disease. Neuropathology. 2009;29(6):649–654.
  • Burrell JR, Kiernan MC, Vucic S, et al. Motor neuron dysfunction in frontotemporal dementia. Brain. 2011;134(Pt 9):2582–2594.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.